Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/2CDCE30B.svg?ark=w1%2F20260515%2F2CDCE30B)](https://nobleid.org/work/w1/20260515/2CDCE30B)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors